MIA–QSAR coupled to principal component analysis-adaptive neuro-fuzzy inference systems (PCA–ANFIS) for the modeling of the anti-HIV reverse transcriptase activities of TIBO derivatives

European Journal of Medicinal Chemistry
2010.0

Abstract

The activities of a series of HIV reverse transcriptase inhibitor TIBO derivatives were recently modeled by using genetic function approximation (GFA) and artificial neural networks (ANN) on topological, structural, electronic, spatial and physicochemical descriptors. The prediction results were found to be superior to those previously established. In the present work, the multivariate image analysis applied to quantitative structure-activity relationship (MIA-QSAR) method coupled to principal component analysis-adaptive neuro-fuzzy inference systems (PCA-ANFIS), which accounts for non-linearities, was applied on the same set of compounds previously reported. Additionally, partial least squares (PLS) and multilinear partial least squares (N-PLS) regressions were used for comparison with the MIA-QSAR/PCA-ANFIS model. The ANFIS procedure was capable of accurately correlating the inputs (PCA scores) with the bioactivities. The predictive performance of the MIA-QSAR/PCA-ANFIS model was significantly better than the MIA-QSAR/PLS and N-PLS models, as well as than the reported models based on CoMFA, CoMSIA, OCWLGI and classical descriptors, suggesting that the present methodology may be useful to solve other QSAR problems, specially those involving non-linearities.

Knowledge Graph

Similar Paper

MIA–QSAR coupled to principal component analysis-adaptive neuro-fuzzy inference systems (PCA–ANFIS) for the modeling of the anti-HIV reverse transcriptase activities of TIBO derivatives
European Journal of Medicinal Chemistry 2010.0
Support vector machines: Development of QSAR models for predicting anti-HIV-1 activity of TIBO derivatives
European Journal of Medicinal Chemistry 2010.0
Adaptive Neuro-Fuzzy Inference System:  An Instant and Architecture-Free Predictor for Improved QSAR Studies
Journal of Medicinal Chemistry 2001.0
A 2D image-based approach for modelling some glycogen synthase kinase 3 inhibitors
Medicinal Chemistry Research 2007.0
Design of potential reverse transcriptase inhibitor containing Isatin nucleus using molecular modeling studies
Bioorganic & Medicinal Chemistry 2010.0
Exploring QSAR of antiamoebic agents of isolated natural products by MLR, ANN, and RTO
Medicinal Chemistry Research 2012.0
CoMFA and CoMSIA analysis of ACE-inhibitory, antimicrobial and bitter-tasting peptides
European Journal of Medicinal Chemistry 2014.0
Comparison of Multiple Linear Regressions and Neural Networks based QSAR models for the design of new antitubercular compounds
European Journal of Medicinal Chemistry 2013.0
Comparative chemometric modeling of cytochrome 3A4 inhibitory activity of structurally diverse compounds using stepwise MLR, FA-MLR, PLS, GFA, G/PLS and ANN techniques
European Journal of Medicinal Chemistry 2009.0
Prediction of Activity for Nonnucleoside Inhibitors with HIV-1 Reverse Transcriptase Based on Monte Carlo Simulations
Journal of Medicinal Chemistry 2002.0